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ABSTRACT
Currently iontophoresis is used by many physical
therapists on a variety of pathological conditions.
Therefore, therapists must have a thorough understanding of
this modality as to provide the best, most efficient care
possible to our patients.
The purpose of this study is to provide clinicians with
a review of the available literature on iontophoresis in
physical therapy. The history and principles of
iontophoresis are briefly discussed, followed by a review of
the clinically performed studies. This section includes
studies related to pain and range of motion, tissue repair,
movement of fluids, and other diagnoses. Animal and in vitro
experimental studies will accompany many of the clinical
studies.
Many of the studies reviewed demonstrated relatively
favorable results, but some of these were conducted in a non
scientific manner. The decision to use iontophoresis must be
made on an individual basis, and the therapist should make
this decision only after reviewing the available literature
on the specific case.
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CHAPTER 1
INTRODUCTION
HISTORY

Iontophoresis

has had many names throughout history,

including; iontransfer,l iontherapy, ion medication,
galvanoionization, and medical ionization. 2 These similar
terms all have a common meaning being the propulsion of ions
through a membrane with the use of electricity.
In 1747, Veratti used iontophoresis to drive lons into
tissue, and this may be the first documented use of
iontophoresis as we know it today. 2,3 The inception of
iontophoresis for medical purposes came about with the work
of Leduc in the early 1900' s. 4,5 This involved the
iontophoresis of strychnine into rabbits ears causing them
to die a few minutes after the current was initiate.
The equipment used for iontophoresis has changed
throughout history. In 1939, a study on the iontophoresis of
copper into the hands and feet of subjects, utilized four
pans of water and copper electrodes. 6 The original power

I
source in this study was a battery to which a rheostat was
connected. The authors indicated that there was potential
for shocking the subject based on the make-break phenomenon.
Eventually they constructed a device in which 110 volt
1

2

current was rectified to direct current. A . similar battery
power source was used by Rapperport et a1 7 in 1965. The
electrodes in this study were assembled using gauze
saturated with aqueous solution of the chosen drug, lead
electrodes, and connection alligator clips.
Today the power sources range from the typical lineoperated DC generator to a battery powered, computerized,
programmable device. 1,2 Depending on the physiological
effects desired and drug chosen, some electrode
configurations continue to use the gauze and tin foil
electrodes 8 similar to that used by Rapperport. 7 Many of the
current systems and common drugs can be applied utilizing
patch electrodes with a self-containing pouch for the drug. 9
PRINCIPLES OF IONTOPHORESIS

In the most simple terms, iontophoresis is defined as
driving specifically charged ions through the skin by the
use of a specific electrical charge. 5,10 Ions are charged
particles and like charges repel. 1 Therefore if a drug is
placed between the skin and the active electrode of the same
charge, using DC galvanic current, the ions will be driven
into the tissue below. The attraction of the ions towards
the dispersive electrode (opposite charge) is insignificant
ln the iontophoresis process according to Barry.10
Studies show evidence that the most probable avenue for
lon transfer is by way of the sweat glands. 2,11,12 However,
the specific mechanism of transfer for some drugs has not
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been established. 13
Historically, continuous galvanic current has been the
current of choice in iontophoresis. 1,8,14 Bagniefski and
Burnette 15 compared pulsed and continuous currents in the
iontophoresis of Na ions on excised mouse skin. They
observed no significant difference in the ion transfer
between pulsed or continuous galvanic current. Pikal and
Shah 14 found similar results showing a slight decrease in
ion transfer with pulsed current. An in vitro study by
Thysman et al 15 concluded that continuous DC current was
more efficient than pulsed. As the duty-cycle or pulsed
current was decreased, the ion transfer also decreased.
DOSAGE

The quantity of lons delivered to the tissue for
therapeutic purposes will depend on three factors:

8

1) Current density under the active electrode where higher
density increases ion transport, 2) Time which current is
allowed to flow,2 and 3) Concentration of ions in the
solution. A low concentration of ions is recommended for
iontophoresis. 1 ,16 A formula using the specific electrochemical equivalency (ECE) is used to determine amounts of
ion transfer. 1 Intensity (amperes) X Time (hours) X ECE

=

grams of ion transferred.
PURPOSE

Currently iontophoresis is used by many physical
therapists on a variety of pathological conditions. Third-

4

party payers, physicians, and patients are beginning to
demand proof that treatments are effective and efficient.
Therefore, therapists must have a thorough understanding of
this modality and which treatments are or are not supported
by research. The purpose of this study is to provide
clinicians with a review of the available literature on
iontophoresis used in physical therapy.

CHAPTER 2
CLINICAL STUDIES: LITERATURE REVIEW

PAIN AND RANGE OF MOTION

Many disorders have pain, inflammation, and/or muscle
spasms as signs and symptoms. A complex cycle can form among
the symptoms with pain causing inflammation and/or muscle
spasms. Each of these can cause an increase in symptoms and
ultimately a spiraling cycle is formed.
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As the cycle

continues, function in the involved area diminishes.
Range of motion (ROM) is one of the early functions to
be limited. Although ROM is not directly affected by the
iontophoretic delivery of specific substances, it can be
altered through reductions in pain. The goal of
iontophoresis is to utilize a specific drug, depending on
its pharmacological effect, to break the pain cycle and
restore the patient to the highest level of function
possible.
Dexamethasone sodium phosphate (DSP)

lS

a commonly

utilized analgesic drug used in iontophoresis. 18 A study by
Glass et al 19 found measurable amounts of DSP could transfer
down to and including tendinous and

c~rtilaginous

though the use of iontophoresis. DSP and lidocaine
5

tissue

6

hydrochloride are two substances frequently used in
combination during iontophoresis. 20 The lidocaine has an
analgesic effect, while DSP is used in many inflammatory
conditions.
Petelenz and associates 21 researched the delivery of
DSP combined with lidocaine in in

V1VO

and in vitro studies.

The in vitro studies demonstrated that significant amounts
of DSP were delivered when the two drugs were combined, but
the amount delivered nearly doubled when DSP was phoresed as
an isolated substance. In vivo studies provided no
significant differences, between positive versus negative
electrode, in the amount of DSP delivered. A study by
Chantraine et a1 22 is not in support of this research, and
failed to provide evidence of the delivery of various
steroids including DSP.
Bertolucci 23 implemented a study to determine the
effects of DSP on pain and range-of-motion (ROM) . Fiftythree subjects were utilize. Diagnoses included:
infraspinatus and supraspinatus tendinitis; adhesive
capsulitis of the shoulder; bicipital tendinitis; lateral
epicondylitis; and sacroiliitis . Subjects were randomly
assigned to a experimental group or a control group. The
experimental group received four treatments of 4 mg/ml DSP
combined with 2 cubic cm of lidocaine hydrochloride at 65
rnA-min each. Pain levels were assessed on day 1 and 3. The
age group which indicated the highest incidence of excellent
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benefits was the 18 to 34 year old group. The thirty-five to
44 year old group indicated significant pain reduction while
only 41% of the subjects in the >45 age group received any
relief from treatment. As the subjects pain decreased their
ROM increased.
weinstein and Gordon 24 studied the effects of
iontophoresis on subdeltoid bursitis based on a chart review
of 50 randomly selected patients. Treatment involved
iontophoresis of a 2% solution of magnesium sulphate at 1020 rnA-min. This was the only treatment administered. In 68%
of these cases all signs and symptoms were alleviated and
full ROM was recovered.
Treatment of trigger areas in shoulder girdle
myofascial syndrome was studied by Delacerda. 25 The study
compared the treatment of DSP iontophoresis with a group
that received muscle relaxants and pain medication and one
that received hot packs and ultrasound. Although all
subjects experienced some pain relief, the iontophoresis
group experienced complete pain relief after day nine.
A study by Harris 9 examined the effects of
iontophoresis on individuals with inflammatory conditions
consisting of tendinitis, bursitis, ligamentous sprains, and
epicondylitis. Fifty subjects received one to three
treatments consisting of 80 rnA-min. The utilized drug was 1
cc of 4 mg dexadron and 2 cc of 4% xylocaine. Evaluation of
treatment effectiveness was based on active range-of-motion
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(AROM)! pain! edema! temperature! and function. The results
indicated that: 75% of the patients had good to excellent
results; 14% had significant decreased pain and increased
strength and ROM; and 11% had little to no decreased pain.
Delacerda 26 found immediate but short-term pain relief from
2.5% xylocaine iontophoresis. Although the focus of a study
by Psaki and Carrol1 27 was on calcium absorption! they found
favorable results in pain reduction and increased ROM.
Individuals with temporomandibular joint (TMJ)
disorders can have secondary symptoms including pain!
inflammation! muscle spasms! and decreased ROM. 17 ,28 Lark and
Gangarosa 29 describe a protocol for the iontophoresis of DSP
in the treatment of individuals with TMJ disorders. Braun 28
describes the use and results of the iontophoretic delivery
of 1 cc DSP and 2 cc lidocaine hydrochloride (4%) in the
treatment of TMJ pathology. In this case study! the patient
received two 80 rnA-min treatments with one day separating
the treatments. The patient also performed a home exercise
program consisting of AROM! stretching! and rhythmic
stabilization exercises. Decreases in pain along with
increases in ROM were reported after the initial treatment
and continued this progression throughout treatment. Results
similar to these were reported by Lark and Gangarosa 29 in
several case studies.
A case study by Kahn 30 focused on paln and decreased
ROM of the TMJ in a subject following minor surgery for

9

infected maxillary sinuses. The subject reported complete
TMJ pain relief after the second treatment of 100 rnA-min
iontophoresis of hydrocortisone ointment followed by three
minutes of ultrasound. ROM was also increased throughout
treatment. Similar relief in pain with hydrocortisone
iontophoresis was reported by Paski et al. 31 but findings by
other researchers were not as supporting. 19,22
The purpose of a study by Paski et al 31 was to
determine the effectiveness of hydrocortisone iontophoresis
on subjects with rheumatoid arthritis (RA) and
osteoarthritis (OA). One-hundred white males between the
ages of 25 and 65 years old were selected as sUbjects.
Thirty subjects were diagnosed with RA and the remainder had
OA. Pain and ROM were assessed at the onset of the study
then weekly for three months. Skin condition and x-ray
results were assessed where applicable. Treatment areas
included the hand, wrists, elbows, shoulders, knees, ankle,
foot,

toes, and back. Chronic cases received treatment

biweekly for at least six weeks and acute cases three times
per week for at least

SlX

weeks. Each area in question

received infrared heat prior to and during treatment.
Hydrocortisone ointment was massaged into the effected area
and current was applied. Subjects with back involvement
received 300 rnA-min of iontophoresis while the remainder of
the subjects received 60-150 rnA-min depending on current
tolerated by each subject.
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Of the subjects with RA, 90% had pain relief and ROM
was restored fully in 50%, but some subjects experienced
increased pain initially followed by decreased pain. In 50%
of the subjects with OA, pain relented entirely and the
remaining cases demonstrated pain reduction. ROM was also
fully recovered in 50% of the sUbjects.
In a study utilizing citrate iontophoresis, Coyer 32
demonstrated only temporary pain relief. Thirty-five
subjects with the diagnosis of and acute exacerbation of RA
were assigned to three groups. Group 1 received 200-300 mAmin of iontophoresis ih a bath containing 2% solution of
potassium citrate and distilled water. Group 2 and 3 were
both control groups, and received tap water iontophoresis
with either negative or positive charge at an average of 20
mAo

The treatment time was not indicated for group 2 or 3.

Treatment was administered every other day for four weeks.
Subjective reports of significant pain relief were
conveyed by 86% of the experimental group, but this effect
wore off throughout the immediate day. Of the control
groups, 90% experienced no pain reduction, while 30%
indicated increased pain and swelling. On the average, grip
strength improved in the citrate iontophoresis group but not
in either control group.
Kahn 33 used iontophoresis of lithium in a subject with
gouty arthritis. He demonstrated immediate short term relief
of pain and long term relief after four weekly treatments.
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The lithium was transferred at a dosage of 100 rnA-min.
Salicylate iontophoresis was found to be effective ln
eliminating prolonged muscle pain post-surgery.34 Nearly two
months post total hip replacement, the subject developed
pain in her rectus femoris. Numerous treatments, including
chloride iontophoresis and mecholyl iontophoresis, were
attempted with minimal success. After three treatments of
salicylate iontophoresis, at 80 rnA-min, the subject reported
significant pain relief. Two months later, thigh pain
returned, but it was eradicated following one salicylate
iontophoreses treatment. A one year follow up on this
subject indicate no return of thigh pain.
Singh and Roberts 35 have demonstrated the depth of
penetration of salicylic acid to be only 3-4 mm. The
concentration of salicylic acid at depths >3-4 mm is not
significantly greater with iontophoresis than with passive
transportation.
Delacerda 26 utilized 12 subjects with shinsplints, SlX
of which had bilateral cases, for a total of 18 cases of
shinsplints. The subjects rated their pain as mild,
moderate, or severe. During each treatment the subject
received 100 rnA-min of iontophoresis at 48 hour intervals. A
limit was set at a maximum of ten treatments. Complete pain
relief was experienced by a group that initially received
xylocaine iontophoresis (2.5%). Since pain returned prior to
subsequent treatment, the xylocaine treatment was
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discontinued after the third treatment and replaced with
hydrocortisone (0.5%) for the remainder of the study. One to
six (average 3.05) treatments were required to eliminate
pain in all of the cases of shinsplints.
Although acute pain may be beneficial, chronic pain
linked to neuralgic and neuralgiform pain syndromes appears
to serve no real purpose. 36 This type of pain is connected
with diagnoses such as: post-discotomie syndrome 37 which can
occur following surgical procedures involving the
intervertebral disk; post-herpetic neuralgia;38 terminal
pain,39 metabolic polyneuropathy, and trigeminal neuralgia.
The remainder of this section on pain will focus on the
use of vinca alkaloid iontophoresis treatment of subjects
with various types of chronic pain secondary to peripheral
nerve lesions. The premise behind this treatment is that the
vinca alkaloids possess the ability to block the retrograde
transmission within the peripheral nervous system. 37 ,39
Research by Knyihar-Csillik et a1 40 supports the
physiological and ionic transport mechanisms of these
procedures.
Csillik and associates 39 studied the e£fects of vinca
alkaloids on subjects with chronic pain secondary to various
diagnoses ranging from intercostal neuralgia to terminal
pain (11 different diagnoses). Fifty-one subjects received
daily vinblastine (0.01%) or vincristine (0.001%)
iontophoresis for eight to 24 days. Subjects each initially
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received placebo treatment for seven to 14 days followed by
vinca alkaloid iontophoresis. Diagnoses of the limbs and
trunk received 600-1800 rnA-min of treatment while areas
involving the head received 120-300 rnA-min. Subjects rated
their pain on a scale of <0-0-100 with 100 being total
elimination of pain, 0 being no change in pain, and a
negative number indicating increased pain. The subjects
received no pain relief from placebo treatment. At a one
year follow-up,

78% of the subjects had experienced no

return of pain, 16% had partial or temporary alleviation of
pain, while 6% had felt no decrease in pain.
Long term pain relief was demonstrated by KnyiharCsillik and colleagues. 4o Subjects (n=48) with approximately
20 different diagnoses and resulting chronic pain were
treated with vinca alkaloid iontophoresis. At a one year
follow up, continuance of pain relief ranged from 0-100%
(mode 100%; mean 91%) with 17% of the subjects experiencing
some type of relapse during that one year period. The
poorest results and highest rate of relapse were experienced
by subjects with trigeminal neuralgia (n=15).
In the study by Csillik et al,39 pain relief
experienced by post-surgical subjects with discopathy was
100% one year post treatment. Penickova and associates 37
reported conflicting

results. They37 used 16 post-

discectomy subjects with chronic (5-16 years) nerve root
pain, and 20 subjects with chronic nerve root pain in the
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dermatomal regions. Numerous conservative and pharmaceutical
approaches had failed to provide any measure of long-term
relief. Initially a 0.01% solution of vinblastine was used,
but this was changed to a protective anode solution allowing
for a maximum of 50 ml of 0.01% vinblastine solution.
Subjects each received 150-450 rnA-min of iontophoresis three
to five times per week until a total of ten treatments had
been administered.
The measures of treatment effect were based on a paln
scale (0-5), a scale rating the effect of pain on ADL's
(0-5), and a modified McGill Pain Questionnaire. These three
categories were assessed to obtain overall treatment
effectiveness (0-5). Mean results from Student's t-tests are
as follows: no improvement 0%; negligible improvement < 9%;
slight improvement 10%-24%; medium improvement 25%-45%; and
considerable improvement> 50%. Although short-term relief
was experienced, only one post-discectomy subject had
continued relief lasting longer than six months in duration.
Sixty-three percent of the subjects had relief for less than
three months. The 150-450 rnA-min treatment, used in this
study compared to Csillik's39 600-1800 rnA-min treatment, may
have been the confounding variable which may explain the
differences in long-term results.
A single blind study was carried out by Layman and
copartners 41 using subjects diagnosed with post-herpetic
neuralgia. The pain in all of the subjects (n=20) had
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previously been unresponsive to treatments which included
TEN's, opiate analgesics, antidepressants, and subcutaneous
infiltration of lignocaine or hydrocortisone.
A solution containing 0.01% vincristine, 0.9% saline,
and 5% dimethyl sulfoxide was delivered to the experimental
group (n=10) while a control group received only saline
iontophoresis. Subjects received treatment three times per
week for a total of 12 treatments at 900-1800 rnA-min
(dependant on subject tolerance). Subjects completed a
three-point ordinal pain scale and a visual analogue pain
scale (VAS) prior to each treatment and at a six week follow
up.
At the close of treatment, 80% of the experimental
group showed improvements on the VAS (mean improvement 59%,
P<0 . 05) compared to 10% showing improvement in the control
group. At six weeks,

60% of the experimental group showed

improvements on VAS (mean improvement 27%, P<0.05).
Comparable pain relief was demonstrated by Tajti et
a1 38 when they evaluated 35 cases of subjects who had been
treated with iontophoresis for post-herpetic neuralgia.
Percentage of pain relief ranged from 28% to 100% (mean
54%). Because these were case studies, treatment parameters
varied and are as follows: 1% vincristine was

combined with

1% hyaluronidase then mixed with distilled water (30ug
vincristine per cm2 of surface tissue); 60-300 rnA-min
treatments for areas of the head and neck; 600-1800 rnA-min
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treatments for the limbs and trunk; each subject receive ten
to 30 treatments. These current-time parameters were very
similar to those used by Csillik and associates. 39
Delacerda 25 researched the use of iontophoresis for the
treatment of myofascial syndrome. The subjects (n=23) job
tasks required them to hold their arm abducted to at least
70° for approximately 15 seconds at a time. Each of the
subjects developed what was diagnosed as shoulder girdle
myofascial syndrome. Seven subjects received pharmaceutical
treatment, eight received hot packs followed by ultrasound,
and eight received iontophoresis of 1 cc DSP (0.4%) combined
with 2 cc lidocaine hydrochloride. The iontophoresis was
delivered at 85 rnA-min for 10 days or to elimination of
pain, which ever came first. The subjects who received
medication continued to have ROM deficits on day 10 along
with two from the ultrasound group. By day 9, all of the
subjects from the iontophoresis group had full pain-free
ROM.
Another potential cause of reduced ROM can be calcium
deposits which may occur in untreated tendinitis or deposits
which form within the muscle itself. If tendinitis is not
treated, calcium deposits can form as a result of decreased
blood supply to the effected area. 27
Absorption of the deposits through acetic acid
iontophoresis was the focus of a study by Psaki and
Carroll.27

Each of 12 subjects received iontophoresis of a
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3% acetic acid solution for 150-300 rnA-min. When the
subjects could raise their arm with minimal assistance,
exercises were initiated. 27 The authors concluded the
following; 1) Calcium deposits were decreased by hyperemia
and hyperacidity in 40% of the cases, as this was identified
through pre and post-treatment x-ray findings, 2) Joint pain
and tenderness disappeared after acetic acid iontophoresis,
and 3) ROM may be completely restored following
iontophoreses of acetic acid.
Results comparable to these were reported in a case
study by Wieder. 42 In a patient with myositis ossificans of
the quadriceps femoris muscle, Wieder 42 reported a 98.9%
reduction in the calcified mass and the return of full knee
ROM following treatment. The iontophoresis consisted of 3 ml
acetic acid (2%) for 80 rnA-min followed by eight minutes of
pulsed ultrasound and passive ROM. Treatment continued three
times per week for three weeks.
Popkin 36 performed two case studies to determine the
effect of hyaluronidase iontophoresis on scleroderma.
Scleroderma is a progressive, systemic syndrome
characterized by hardening and thickening of the skin and
ultimately decreased ROM. Hyaluronidase hydrolyses
hyaluronic acid36 is a substance which plays a part in the
arrangement of the collagen matrix. Popkin 36 performed two
case studies to determine the effect of hyaluronidase
iontophoresis on scleroderma. In both of the studies he
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found that during treatment signs and symptoms were
diminished and the subjects perceived substantial benefits
including increased ROM. The benefits were determined to be
only short-term.
The iontophoresis of iodine ion was used by Langl ey43
to treat tendon adhesions, and Tannenbaum44 in reducing
post-surgical scar tissue. Both case studies utilized an
Iodex ointment at and 80 and 100 rnA-min of treatment
respectively. After five consecutive daily treatments,
Tannenbaum44 found the return of normal ROM and an increase
in muscle strength from trace to good. At a six month
follow-up both ROM and strength were normal. Langl ey 43 found
similar results after three daily treatments. These two case
studies demonstrate the possibility of scar reduction
through the use of iontophoresis.
TISSUE REPAIR

The physiological basis and the value of zinc ions in
tissue repair has been discussed by various researchers. 4,45
When zinc is introduced into the tissue, insoluble
precipitates are formed with tissue components, and this
aids in the epithelialization of granular tissue. 45 Zinc ion
is also considered to be antibacterial.
Cornwal1 46 investigated the clinical effectiveness of
zinc iontophoresis in healing ischemic ulcers. The subject
had bilateral ulcers secondary to BK amputations. In this
case study, zinc-oxide ointment (0.1 mole solution) was
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applied proximal to the lesion and transferred into the
underlying tissue with approximately 68 rnA-min iontophoresis
b.i.d. for 20 days. The author demonstrated >98% closure of
both ulcers at the end of the 20 day period.
Abramson and associates 47 studied the effects of
histamine iontophoresis on 14 subjects with various ulcers.
The affected extremity was placed in a solution (0.0001%) of
histamine diphosphate, and iontophoresis was administered at
60 rnA-min two to three times per week. Complete healing of
trophic changes occurred in four of the subjects with
progressive systemic sclerosis (n=5), while the fifth
subject showed some improvements. Subjects with sickle cell
anemia (n=4), neurotrophic ulcers (n=l), and venous stasis
ulcers (n=l) all demonstrated improvements, while those with
ischemic ulcers secondary to arteriosclerosis (n=3) showed
no improvements.
Recurrent herpes labialis (RHL) are lesions caused by
herpes simplex virus (HSV)

.48

If left untreated, HSV can

lead to blindness, encephalitis, and cancer. Healing of the
lesions usually requires seven to ten days which allows the
lesions to transmit to other areas of the body or to other
individuals through venereal contact. Burning, itching and
severe scabbing generally accompanies healing.
Gangarosa et a1 48 performed a study which produced 20
separate trials, six control (C) and 14 experimental (E),
from six subjects. The C group (non-blind) received no
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treatment while the E group received 3-5 rnA-min of
idoxuridine solution (0.1%). Treatment duration was until
healing was complete usually within 3.4 days (+-0.3) for E
compared to 8.8 days (+-1.1) for C group. The lesions in the
E group also healed with less discomfort and scabbing.
MacCullum and Jensen 49

reported a comparable average of 8.9

days for healing in treatment by topical idoxuridine
ointment without the assistance of iontophoresis. Gangarosa
and associates 5o feel the reason that topical ointments are
unsuccessful is not due to drug ineffectiveness, but
secondary to lack of ion transfer without the assistance of
iontophoresis.
Herpetic whitlow is another type of lesion generally
caused from HSV . 51 The lesions occur on the fingers which
provide for an easy method of transmission to additional
body regions or other individuals. Gangarosa and collages 51
reported on two case studies involving the iontophoresis of
idoxuridine (0.1%) in two subjects with herpetic whitlow.
Each lesion was treated with at least 0.5 rnA of current for
ten minutes, and larger lesions received proportionately
increased dosages. One subject exhibited a 60% decrease in
healing time and an 80% reduction in severity. This subject
experience no return of the lesions at 38 months posttreatment. A second subject experience decreased pain,
resolved HSV lesions, and lacked recurrent lesions at 48
months post-treatment.

21
Twenty-seven subjects diagnosed with RHL of the oral
region participated in a double blind, placebo controlled
study conducted by Gangarosa and associates. 5o

The study

utilized one control group (C) and two experimental groups

(E 1,E 2 ) . E1 received iontophoresis of vidarabine
monophosphate (5.2% solution), E2 received acyclovir (3.5%
solution), and C received NaCI (0.9%) solution. These
concentrations allowed for an equal number of ions per ml of
solution . Current-time settings were at 4.0 rnA-min for all
subjects, and a total of eight treatments were administered
over a three week period. The E1 group had significantly
lower (P<0 . 05) titers of the virus than either E2

or C

after a 24 hour period, but the number of healing days was
not significantly different. The authors suggested that a
single treatment with vidarabine monophosphate may be
sufficient to offer significant benefits.
The purpose of three case studies by LaForest and
Cofrancesco

52

was to study the treatment of burned ears with

gentamicin sulphate iontophoresis. Two subjects (Sl & S2)
were positioned in sideling with the burned ear immersed in
a gentamicin sulphate solution (5mg/ml water) at 5-10 and 35
rnA-min respectively. One subject (S3) received gentamicin
sulphate (8mg/ml water) iontophoresis at a dosage of 75 rnAmin. S3 used a solution soaked gauze pad electrode for ion
transfer. Sl experienced epithelialization after 12
treatments/7 days, and had no recurrence at 27 months.
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Epithelialization for S2 occurred after 24 treatments/13
days and the subject suffered no recurrence at 8 months. The
ear of the final subject, S3 had healed following 28
treatments over a 15 day period. This subject experienced no
recurrence at 18 months post-treatment . Sela and
associates 53 propose molding a prosthetic device for the ear
to eliminated the need for ear immersion during
iontophoresis.
The transfer of antibiotic ions is supported by
Rapperport et al. 7 In a double blind study, they
demonstrated significant (P<O.Ol) levels of penetration of
penicillin through burn eschar. This research involved
studies of both human and animal sUbjects.
The purpose of a study by Haggard et a1 6 was to
determine the effect of copper iontophoresis on fungal
infections of the hands and feet. Iontophoresis was
administered to 37 subjects who had been diagnosed with
dermatophytosis. Each subject received treatment two or
three times per week at a dosage of 80-120 rnA-min if one
extremity was treated or 160-200 rnA-min if both extremities
were treated simultaneously. If the hands were infected they
were place in a 0.2% copper sulfate solution with the active
electrode while the feet were place in a saline solution
with the dispersive electrode. This arrangement was reversed
if the feet were infected, and if both were infected the
subject received two 20 minute treatments. Seventy percent
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of the subjects obtained a clinical cure after an average of
six treatments. Eighty-eight percent of these subjects ere
followed for a period of three to six months, with 22%
suffering some type of recurrence.
Jersild and Plesner 54 followed-up 35 subjects who had
received copper iontophoresis (0.001% solution) in the
treatment of epidermophytia of the hands and feet.
Iontophoresis was administered at 100-300 rnA-min every other
day for a total of two to five treatments (85%) or six to 11
treatments (15%). Of these 35 subjects, 87.5% had
experienced no reappearance of the epidermophytia.
It has been demonstrated that silver ions are effective
bactericidal agents. 55,56 Becker and Spadaro 55 studied the
effects of silver ion on chronic osteomyelitis with nonunion of the bone. Prior to iontophoresis, surgical
debridement was used to remove necrotic tissue and drain
infection. Two separate treatment protocols were used. One
of the protocols consisted of a pure silver wire electrode
that was implanted into the bone if wounds could be
surgically closed. These subjects received continuous
iontophoresis at 1 microampere per centimeter of exposed
wire for the first 24 hours. The dosage was then reduced to
100 nanoampers. This dosage was maintained for approximately
six weeks until 1.5 to 2.5 joules of total energy were
delivered. An alternate protocol was used when the wound was
required to be left open. This involved using a silver

24
impregnated nylon fabric as the electrode. This nylon
material was packed into the wound site and wrapped with a
sterile dressing. Current was regulated at 0.9 volts .
Control of the infection was achieved in 12 out of 15
treatments. Healing of non-unions also occurred in these 12
subjects after a period of 3-36 months. Control of the
infection was not complete in the remaining three
treatments.
Satyanand and associates 56 used procedures very similar
to the first treatment technique used by Becker and
Sparado. 55 Out of the 50 subjects treated, 22 experienced
good outcomes, 18 fair, and ten poor. The best results were
experienced by those with Staphylococcus infections (38%),
and the poorest results by subjects with Proteus infections
(14%) .

The silver impregnated fabric method of ion transfer is
supported by Falcone et al. 57 They demonstrated
significantly larger inhibitory zones when the silver
iontophoresis was versus control groups.
MOVEMENT OF FLUIDS

Iontophoresis may be used to effect fluid flow in an
attempt to: 1) Control edema; 2) Increase blood flow and
nutrients to an injured area; or 3) In some cases, such as
hyperhidrosis, the clinician wants to decrease the flow of
fluids.
The purpose of a study by Schwartz 58 was to determine
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the effectiveness of hyaluronidase by iontophoresis in
treating lymphedema. Hyaluronidase decreases the viscosity
of fluids allowing them to move freely within the
circulatory system. The subjects (n=5) extremity was wrapped
in a cloth containing hyaluronidase dissolved in an acetate
buffer solution. Control iontophoresis treatments (inert
buffer solution) were randomly substituted for the
hyaluronidase treatments throughout the study. Each subject
received 400-600 rnA-min of iontophoresis. Volumetric
measurements were taken pre and post treatment. Results
indicate that the treatment was effective, but carryover
between treatment required the use of an elastic compression
wrap over the effected extremity. The control treatments
(mean=4.8) had and 18.4 cc mean reduction in volume compared
to the hyaluronidase treatment (mean=20.6) which had a 224.1
cc mean reduction in volume.
Kahn 33 demonstrated elimination of soft tissue edema
after four treatments in a single case study involving a
subject with gouty arthritis. The iontophoresis consisted of
a 2% solution of lithium chloride delivered at 100 rna-min
per treatment.
Kovacs et a1 59 have established that Acetyl-B-MethylCholine (ABMC) is a strong vasodilator. Macht and
associates 60 studied the effectiveness of ABMC (0.2%)
iontophoresis on blood flow. A total of 31 separate
experiments were performed on six sUbjects. Blood flow was
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measured using a venous occlusion fluid-air plethysmograph.
The subjects initially rested in a temperature controlled
experiment room for one hour. The hand was then placed in
the temperature controlled ABMC bath for 30 minutes, after
which a baseline blood flow measurement was taken.
Iontophoresis was then carried out at 300-540 rnA-min with
blood flow measurements taken at five to ten minute
intervals. Significant increases in blood flow (up to 20
times the control) were demonstrated by the iontophoresis of
ABMC. The 2 controls (ABMC immersion without current and
iontophoresis of saline solution) experienced no significant
changes in blood flow. Parameters very similar to these were
used by Abramson et a1 61 with the exception of decreased
current-time dosages (5-15rnA for 10-20min). This study
included tests on the forearm (n=17), leg (n=8) , and foot
(n=5). It was demonstrated that the increased blood flow
during ABMC iontophoresis returned to near baseline after an
average of 33-58 minutes post-treatment. The study also
showed that the vasodilatation which occurred during
iontophoresis was primarily in the superficial/cutaneous
circulation rather than in the deeper vessels.
Abramson et a1 47 conducted a study on 16 subjects to
determine the effect which histamine iontophoresis has on
blood flow and blood oxygen content. Blood flow was measured
with a segment type venous occlusion plethysmograph, and
blood oxygenation was measured by the manometric method. The
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oxygen uptake was calculated using the Fick principle. The
histamine diphosphate solution (0.0001%) was transferred
using 140-300 rnA-min iontophoresis. The results of this
experiment show a significant increase in blood flow during
treatment which continued for approximately 65 minutes after
the iontophoresis ended. In 93% of the experiments,
calculated oxygen uptake fell during early treatment. While
60% of these remained below the baseline throughout
treatment, 40% rose back to baseline or above. The authors
offered several possible explanations for this occurrence.
Hyperhidrosis is a condition in which the individual
experiences excessive, abnormal sweating of the hands, feet,
axilla and/or trunk. 62 Shrivastava and Singh 63 researched the
use of tap water iontophoresis in hyperhidrosis. Thirty
subjects with plantar and palmar hyperhidrosis completed
this study. The 30 subjects were divided into three groups,
each with two subgroups . Group 1 received iontophoresis with
both electrodes in the same pan, and one subgroup received a
dosage of 400 rnA-min compared to 625 rnA-min for the
remaining sUbjects. In group 2 the electrodes were not
placed in the same pan, and treatment time varied providing
a dosage of 150 rnA-min for one subgroup and 250 rnA-min for
the other. Treatment dosage for group 3 varied from 150-400
rnA-min depending on the subjects tolerance. Water level In
all treatments was adjusted to just cover the palmar or
plantar surface. Anhidrosis was experienced by all 30
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subjects. Variation in treatment dosage did not demonstrate
significant increased benefits (P>0.05), but the number of
treatments required for anhydrosis was significantly less
(P<O.Ol) when electrodes were place in separate pans. Mean
duration of anhydrosis was 5.86 months, but this varied from
subject to subject and treatment group to group.
Other researchers 64 ,65 have demonstrated that tap water
iontophoresis provided only short term benefits, and

was

not as effective as using an anticholinergic solution. Grice
et a1 64 compared the iontophoresis of tap water to a poldine
methosulphate (PMS) solution (.05%-.075% solution) in the
treatment of palmar, plantar, and axillary hyperhidrosis.
Method of current delivery was similar to that used by
Shrivastava and Sing 63 , but subjects with axillary
hyperhidrosis were treated with a gauze covered electrode
soaked in the chosen solution. Iontophoresis was
administered weekly for six to eight weeks. The dosage for
the hands and feet was 15-20 rnA-min and 10-15 rnA-min for the
axilla. Nine subjects received PMS iontophoresis while the
other received tap water iontophoresis. In each subject, one
side of the body received iontophoresis while the other did
not, thus providing a control.
Neither tap water nor PMS provided adequate control of
axillary hyperhidrosis. While PMS provided quicker and
generally a longer duration of anhidrosis, neither treatment
provided long term relief. These authors agree with Morgan 66
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in that there is a possibility for a systemic effect and
side-effect when using anticholinergic solutions. Table 1
summarizes research studies on iontophoresis .

Table 1.

Substances Delivered by Iontophoresis

Substance

Polarit~,b

Acetlc ACld
Acyclovir
Atropine sulfate
Calcium
Chlorine
Citrate
Copper
Dexamethasone

NEG
pas
pas
pas
NEG
NEG
pas
pas

Glycopyrronium
Bromide
Gentamicin sulfate
Histamine
Hyaluronidase

pas

Hydrocortisone

pas

Idoxuridine
Iodine

NEG
NEG

Lidocaine

pas

Lithium chloride
Magnesium

pas
pas

Mecholyl

pas

pas
pas
pas

Penicillin
NEG
Poldine methylsulfate NEG
Salicylate
NEG
Silver
Vidarabine
Monophosphate
Vincristine/-blastine

pas
pas

Water
Xylocaine
Zinc

pas/NEG
pas
pas

a
b

NEG
pas

pas

Purpose/Pathology
Calclum Deposlts, calclfled tendlnltls
Herpes simplex
Hyperhidrosis
Frozen joints
Muscle pain
Rheumatoid arthritis
Fungus infection
Inflammation, myofascial syndromes
arthritis, TMJ
Hyperhidrosis
Ear chondritis, antibiotic
Ulcers, blood flow
Absorption enhancement, edema, scleroderma,
lymphedema
Arthritis, tendinitis, myositis, bursitis,
chronic pain, TMJ
Herpes simplex
Sclerotic, fibrosis, adhesions,
scar tissue, trigger finger
Inflammation,Skin anesthesia,
TMJ, pain, arthritis
Gouty tophi
Muscle relaxant, vasodilator, pain,
inflammatory conditions
Vasodilator, ulcers, arthritis, ischemia
edema
Infected burn wounds, antibiotic
Hyperhidrosis
Analgesic,
scar tissue,adhesive joints,
pain, inflammation, edema
Chronic osteomyelitis, bactericidal, ulcers
Herpes simplex
Chronic pain, post-herpetic neuralgia,
trigeminal neuralgia
Hyperhidrosis
Shin splints
Asepsis, ulcers, dermatitis, wound healing

Negatively Charged Substances
positively Charged Substances
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Reference
27, 42
50
62
1

34
32
6,54
9,19-21,23,25
28
62,66
52,53
47
36,38,58
1,22,26,30
48-51
43,44
9,20,23,25 , 26
28,29,35
33
I, 24
34,59-61
7
62,64
1,34,35,43

55-57
50
37-41
62,63
9,26
4,45,46

CHAPTER 3
CONCLUSION

Iontophoretic procedures as used in physical therapy
related conditions have been explored. Numerous studies
concentrated on decreasing pain and increasing ROM in
various pathological conditions. Several relatively
objective studies on primarily acute pain indicate favorable
results, but other research is not in total agreement. The
relief of chronic pain is well documented and supported by
various researchers, but the effects may be only short term.
Iontophoresis use by physical therapists to assist in tissue
repair is not new. Conditions commonly treated include
ulcers, burns, HSV lesions, and fungal infections.
Iontophoresis has also been used as a bactericidal agents.
Research supports the use of iontophoresis in treating
neurotrophic and venous stasis ulcers. Iontophoresis has
also been used in an attempt to control edema, increase
blood flow, and decrease sweat production. While most
research indicated favorable results, the effects were not
always found to be long term.
Repeated research on a single condition, with a
specific drug, were rather limited. In my opinion, the
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majority of these studies were non scientific, with no
control groups. Most studies did not include specific
treatment guidelines. Although the studies contained
clinically applicable information, most of them were unable
to demonstrate any level of cause and effect.
From this independent study I have formulated two
recommendations. First, that clinicians continue to perform
research while striving to conduct it in a more scientific
manner. This is needed to provide proof of efficiency to
those who are currently requiring it. Second, I would
recommend that therapist utilizing iontophoresis do so In an
informed manner. The decision to use iontophoresis should be
based on an experimental foundation considered specifically
for the ion and pathological condition in question.
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